Anti-PD-1 Antibody Combined With Pegaspargase in the Treatment of Advanced Stage NK/T-cell Lymphoma

Condition:   Nasal Type Extranodal NK/T-Cell Lymphoma Interventions:   Drug: Pegaspargase;   Drug: Anti-PD-1 monoclonal antibody Sponsor:   Ruijin Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials